Somaliland Science Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Somaliland Science Reporter.

Press releases published on August 28, 2026

Aug. 28, 2026

New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients

Indeterminate GlobeNewswire

Aug. 28, 2026

Humanity's Team Sees a Common Thread in Nepal Floods, AI Water Strain and Job Risk

Indeterminate EIN Presswire

Aug. 28, 2026

Nano Labs Announces First Half of 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 28, 2026

Rezolve Ai and Tech Mahindra Forge Global Alliance to Bring Agentic Commerce to Enterprise Scale

Indeterminate GlobeNewswire

Aug. 28, 2026

Core AI Holdings Reports 56% Q2 Revenue Growth and Significant Improvement in Gross Margin

Indeterminate GlobeNewswire

Aug. 28, 2026

Calian Announces Normal Course Issuer Bid and Filing of Short Form Base Shelf Prospectus

Indeterminate GlobeNewswire

Aug. 28, 2026

SalesCloser Reports Third Quarter Fiscal 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Aug. 28, 2026

Questor Announces Second Quarter Results

Indeterminate GlobeNewswire

Aug. 28, 2026

iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 28, 2026

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

Indeterminate GlobeNewswire

Aug. 28, 2026

Jiayin Group Inc. Reports Second Quarter 2026 Unaudited Financial Results

Indeterminate GlobeNewswire

Aug. 28, 2026

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

Aug. 28, 2026

Chiesi Global Rare Diseases Demonstrates Its Ongoing Commitment to the Rare Disease Community at the Society of Inborn Errors of Metabolism (SSIEM) 2026 Annual Symposium

Indeterminate GlobeNewswire

Aug. 28, 2026

OSE Immunotherapeutics organisera un webcast dédié à lusvertikimab avec des leaders d’opinion le 2 septembre 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026

Indeterminate GlobeNewswire

Aug. 28, 2026

StoreClaw Concludes Participation at MDS Singapore Summit 2026

Indeterminate GlobeNewswire